Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flex...

Por Ginsberg, Y., Arngrim, T., Philipsen, A., Gandhi, P., Chen, C.-W., Kumar, V., Huss, M.
Publicado no CNS Drugs (2014)

Reproducibility of ultrasonography for assessing abdominal fat distribution in a population at high risk of diabetes

Por Philipsen, A, Carstensen, B, Sandbaek, A, Almdal, T P, Johansen, N B, Jørgensen, M E, Witte, D R
Publicado em 2013

Functional improvement and correlations with symptomatic improvement in adults with attention deficit hyperactivity disorder receiving long-acting methylphenidate

Por Buitelaar, J. K., Casas, M., Philipsen, A., Kooij, J. J. S., Ramos-Quiroga, J. A., Dejonckheere, J., van Oene, J. C., Schäuble, B.
Publicado em 2012